Mr. Haidamus, our Chairman of the board of directors and Chief Executive Officer since our inception in June 2021, has significant experience leading, advising and effecting turnaround plans at both public and private technology companies. From January 2019 through November 2020, Mr. Haidamus served as President and Chief Executive Officer of Immersion Corporation (NASDAQ: IMMR) where he was brought in to turn the company around, create new strategic goals and reach profitability.

Prior to Immersion, Mr. Haidamus was President of Nokia Technologies (“Nokia”), a $1.3 billion organization, from September 2014 to October 2016. He joined Nokia shortly after the divestiture of the mobile business to Microsoft Corporation and worked diligently to raise morale and redefine a new purpose for the consumer-oriented company. While at Nokia, Mr. Haidamus restructured Nokia by creating new divisions and accelerating growth in the existing patent licensing division.

Specifically, Mr. Haidamus created the digital media division (which provided the movie industry with professional quality Virtual Reality OZO cameras) and the digital health division (in which Mr. Haidamus created a world-class research center for consumer wearables and patient monitoring). This resulted in the acquisition of Withings S.A. in 2016 for $200 million and led Nokia back to the consumer product business. He partnered with Nokia affiliates Nokia Networks and HERE division to acquire and integrate Alcatel-Lucent in 2015.

Mr. Ferrari, a member of our board of directors and our President since our inception in June 2021, is a seasoned senior executive whose career has focused on the transformative leadership of health and wellness companies.

Most recently from May 2018 to June 2020, he was the President of Americas for WOW Tech Group, an innovative company focused on health and wellness.

After serving as a member of the board of directors of Standard Innovation Corporation from November 2008 to June 2020. Mr. Ferrari took on the role of President of Standard Innovation Corp (“SIC”) from November 2014 until June 2020, where he led a turnaround by transitioning the business development model to focus on higher-margin channels and added a number of new products and software services to make the product portfolio appealing to additional demographics and potential investors.

After helping SIC return to growth, Mr. Ferrari was part of a team at SIC that negotiated a merger with a European competitor.

Mr. Ferrari has also held senior leadership positions at Keystream, an IT consulting company, from April 1998 to March 2014, as well as Obotics, a consumer health and wellness technology startup, from January 2013 to May 2016.

Mr. Ferrari has a Bachelor of Commerce from Carleton University.

Dr. Blair, a member of our board of directors since September 2021, is the founder and Chief Science Officer of the digital health start-up, Lover, and is also the founder of The Clinic, an independent wellness clinic in the California Bay Area. Dr. Blair is a licensed clinical psychologist and a board certified behavioral sleep medicine specialist in the San Francisco Bay Area. Dr. Blair is also board certified in medicine and provides therapy services to individuals and couples.

With locations across the state of California, The Clinic is led by Dr. Blair. Dr. Blair has extensive clinical and research expertise in behavioral medicine with specializations in sleep and health. She has made numerous presentations, developed and led workshops, written book chapters and published articles in the area of sleep and medicine. She is a Stanford consultant and is on the adjunct faculty at The Stanford Center for Sleep Sciences and Medicine.

Dr. Blair founded Lover as a way to use digital channels, such as telehealth, to provide accessible wellness resources and community building to a greater number of people.

Dr. Blair completed her postdoctoral fellowship at Stanford University Medical School and her predoctoral internship at the VA Greater Los Angeles Healthcare System. Dr. Blair received her doctoral degree in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium. She received a B.A. degree in Psychology from the University of California at Berkeley.

Dr. Verdin, our advisor since our inception in June 2021, is the President and Chief Executive Officer of the Buck Institute for Research on Aging (the “Buck”). Dr. Verdin joined the Buck in 2016 after spending 20 years as a senior investigator at the Gladstone Institutes, where he served as associate director from 2004 to 2016. A native of Belgium, Dr. Verdin received his M.D. from the University of Liege in 1982 followed by additional clinical and research training at Harvard Medical School. He has held faculty positions at several universities and medical research institutes, including the University of Southern California since 2016, the University of California, San Francisco since 1999, the University of Brussels from 1987 to 1990, the National Institutes of Health (NIH) from 1990 to 1993 and the Picower Institute for Medical Research (1994 – 1997).

Dr. Verdin has been recognized for his research with multiple awards including a Glenn Award for Research in Biological Mechanisms of Aging and a senior scholarship from the Ellison Medical Foundation. He is an elected member of several scientific organizations, including the American Association for the Advancement of Science, the American Society for Clinical Investigation and the Association of American Physicians. He also served on the advisory council of the National Institute on Drug Abuse at the NIH. He will bring his decades of experience in virology, aging, wellness, as well as other cutting-edge research projects expertise.